The DOI matches its Crossref record; 108 of the 108 references it cites were found in a registry or an index.
The Role of BCL2 Family of Apoptosis Regulator Proteins in Acute and Chronic Leukemias
Open accessAbstract
The disturbance of apoptosis molecular signaling pathways is involved in carcinogenesis. BCL2 family of proteins is the hallmark of apoptosis regulation. In the last decade, new members of BCL2 gene family were discovered and cloned and were found to be differentially expressed in many types of cancer. BCL2 protein family, through its role in regulation of apoptotic pathways, is possibly related to cancer pathophysiology and resistance to conventional chemotherapy. It is well known that leukemias are haematopoietic malignancies characterized by biological diversity, varied cytogenetics, different immunophenotype profiles, and diverse outcome. Current research focuses on the prognostic impact and specific role of these proteins in the pathogenesis of leukemias. The understanding of the molecular pathways that participate in the biology of leukemias may lead to the design of new therapies which may improve patients' survival. In the present paper, we describe current knowledge on the role of BCL2 apoptosis regulator proteins in acute and chronic leukemias.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Green, D. R., & Reed, J. C. (1998) · Science · doi:10.1126/science.281.5381.1309 · Cited by 8,965
The Bcl-2 Protein Family: Arbiters of Cell Survival
Adams, J. M., & Cory, S. (1998) · Science · doi:10.1126/science.281.5381.1322 · Cited by 5,332
The BCL-2 protein family: opposing activities that mediate cell death
Youle, R. J., & Strasser, A. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2308 · Cited by 4,679
The Bcl2 family: regulators of the cellular life-or-death switch
Cory, S., & Adams, J. M. (2002) · Nature Reviews Cancer · doi:10.1038/nrc883 · Cited by 4,032
Darnell, J. E. (1997) · Science · doi:10.1126/science.277.5332.1630 · Cited by 3,979
Luo, X., Budihardjo, I., Zou, H., Slaughter, C., & Wang, X. (1998) · Cell · doi:10.1016/s0092-8674(00)81589-5 · Cited by 3,626
miR-15 and miR-16 induce apoptosis by targeting BCL2
Cimmino, A., Calin, G. A., Fabbri, M., Iorio, M. V., Ferracin, M., Shimizu, M., Wojcik, S. E., Aqeilan, R. I., Zupo, S., Dono, M., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506654102 · Cited by 3,517
An inhibitor of Bcl-2 family proteins induces regression of solid tumours
Oltersdorf, T., Elmore, S. W., Shoemaker, A. R., Armstrong, R. C., Augeri, D. J., Belli, B. A., Bruncko, M., Deckwerth, T. L., Dinges, J., Hajduk, P. J., et al. (2005) · Nature · doi:10.1038/nature03579 · Cited by 3,416
Zha, J., Harada, H., Yang, E., Jockel, J., & Korsmeyer, S. J. (1996) · Cell · doi:10.1016/s0092-8674(00)81382-3 · Cited by 2,595
Mitochondria and cell death: outer membrane permeabilization and beyond
Tait, S. W. G., & Green, D. R. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2952 · Cited by 2,593
Direct Activation of Bax by p53 Mediates Mitochondrial Membrane Permeabilization and Apoptosis
Chipuk, J. E., Kuwana, T., Bouchier-Hayes, L., Droin, N. M., Newmeyer, D. D., Schuler, M., & Green, D. R. (2004) · Science · doi:10.1126/science.1092734 · Cited by 2,108 · cited 1×
“P53 can activate BAX, which lacks a clearly identifiable BH3 domain [32].”
BackgroundSphingosine-1-phosphate: an enigmatic signalling lipid
Spiegel, S., & Milstien, S. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1103 · Cited by 2,075
ABT-263: A Potent and Orally Bioavailable Bcl-2 Family Inhibitor
Tse, C., Shoemaker, A. R., Adickes, J., Anderson, M. G., Chen, J., Jin, S., Johnson, E. F., Marsh, K. C., Mitten, M. J., Nimmer, P., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5836 · Cited by 1,992
Kuwana, T., Bouchier-Hayes, L., Chipuk, J. E., Bonzon, C., Sullivan, B. A., Green, D. R., & Newmeyer, D. D. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.02.003 · Cited by 1,185
Tsujimoto, Y., Gorham, J., Cossman, J., Jaffe, E., & Croce, C. M. (1985) · Science · doi:10.1126/science.3929382 · Cited by 991
Keating, M. J., O’Brien, S., Albitar, M., Lerner, S., Plunkett, W., Giles, F., Andreeff, M., Cortes, J., Faderl, S., Thomas, D., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.12.051 · Cited by 950
BID: a novel BH3 domain-only death agonist.
Wang, K., Yin, X. M., Chao, D. T., Milliman, C. L., & Korsmeyer, S. J. (1996) · Genes & Development · doi:10.1101/gad.10.22.2859 · Cited by 946
MiR-15a and miR-16-1 cluster functions in human leukemia
Calin, G. A., Cimmino, A., Fabbri, M., Ferracin, M., Wojcik, S. E., Shimizu, M., Taccioli, C., Zanesi, N., Garzon, R., Aqeilan, R. I., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800121105 · Cited by 808
Structural biology of the Bcl-2 family of proteins
Petros, A. M., Olejniczak, E. T., & Fesik, S. W. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2003.08.012 · Cited by 745
Kitada, S., Andersen, J., Akar, S., Zapata, J. M., Takayama, S., Krajewski, S., Wang, H.-G., Zhang, X., Bullrich, F., Croce, C. M., et al. (1998) · Blood · doi:10.1182/blood.v91.9.3379 · Cited by 651
The CD95 (APO-1/Fas) and the TRAIL (APO-2L) Apoptosis Systems
Walczak, H., & Krammer, P. H. (2000) · Experimental Cell Research · doi:10.1006/excr.2000.4840 · Cited by 628
Del Gaizo Moore, V., Brown, J. R., Certo, M., Love, T. M., Novina, C. D., & Letai, A. (2007) · Journal of Clinical Investigation · doi:10.1172/jci28281 · Cited by 608
BCL2 family in DNA damage and cell cycle control
Zinkel, S., Gross, A., & Yang, E. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401987 · Cited by 474
Diversity in the Mechanisms of Neuronal Cell Death
Yuan, J., Lipinski, M., & Degterev, A. (2003) · Neuron · doi:10.1016/s0896-6273(03)00601-9 · Cited by 474
Reed, J. C. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401975 · Cited by 473
Constitutive activation of STAT5 by the BCR-ABL oncogene in chronic myelogenous leukemia.
Shuai, K., Halpern, J., ten Hoeve, J., Rao, X., & Sawyers, C. L. (1996) · PubMed · Cited by 434
Bax cleavage is mediated by calpain during drug-induced apoptosis
Wood, D. E., Thomas, A., Devi, L. A., Berman, Y., Beavis, R. C., Reed, J. C., & Newcomb, E. W. (1998) · Oncogene · doi:10.1038/sj.onc.1202034 · Cited by 331
Mcl-1 is a potential therapeutic target in multiple types of cancer
Akgul, C. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8637-6 · Cited by 329
Vogler, M., Butterworth, M., Majid, A., Walewska, R. J., Sun, X.-M., Dyer, M. J. S., & Cohen, G. M. (2009) · Blood · doi:10.1182/blood-2008-08-173310 · Cited by 323
How cells die: Apoptosis pathways☆☆☆
Zimmermann, K. C., & Green, D. R. (2001) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2001.117819 · Cited by 321
Robertson, L. E., Plunkett, W. K., McConnell, K., Keating, M. J., & McDonnell, T. J. (1996) · PubMed · Cited by 281
Modulation of NF-κB Activity and Apoptosis in Chronic Lymphocytic Leukemia B Cells
Furman, R. R., Asgary, Z., Mascarenhas, J. O., Liou, H.-C., & Schattner, E. J. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.4.2200 · Cited by 278
Freytag, S. O. (1988) · Molecular and Cellular Biology · doi:10.1128/mcb.8.4.1614 · Cited by 271
Aichberger, K. J., Mayerhofer, M., Krauth, M.-T., Skvara, H., Florian, S., Sonneck, K., Akgul, C., Derdak, S., Pickl, W. F., Wacheck, V., et al. (2005) · Blood · doi:10.1182/blood-2004-02-0749 · Cited by 253
Mitochondrial signaling in cell death via the Bcl-2 family
Leibowitz, B., & Yu, J. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.9.6.11392 · Cited by 247
BCL-2 in the crosshairs: tipping the balance of life and death
Walensky, L. D. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401992 · Cited by 246
BCL2 Family of Apoptosis-Related Genes: Functions and Clinical Implications in Cancer
Thomadaki, H., & Scorilas, A. (2006) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360500295626 · Cited by 245
Self-citationCuní, S., Pérez-Aciego, P., Pérez-Chacón, G., Vargas, J. A., Sánchez, A., Martín-Saavedra, F. M., Ballester, S., García-Marco, J., Jordá, J., & Durántez, A. (2004) · Leukemia · doi:10.1038/sj.leu.2403398 · Cited by 241
Transforming Growth Factor-β1 Increases Bad Phosphorylation and Protects Neurons Against Damage
Zhu, Y., Yang, G.-Y., Ahlemeyer, B., Pang, L., Che, X.-M., Culmsee, C., Klumpp, S., & Krieglstein, J. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-10-03898.2002 · Cited by 224
BCL-2 dependence and ABT-737 sensitivity in acute lymphoblastic leukemia
Del Gaizo Moore, V., Schlis, K. D., Sallan, S. E., Armstrong, S. A., & Letai, A. (2008) · Blood · doi:10.1182/blood-2007-06-098012 · Cited by 223
Marcucci, G., Byrd, J. C., Dai, G., Klisovic, M. I., Kourlas, P. J., Young, D. C., Cataland, S. R., Fisher, D. B., Lucas, D., Chan, K. K., et al. (2003) · Blood · doi:10.1182/blood-2002-06-1899 · Cited by 222
Clinical relevance of BCL-2 overexpression in childhood acute lymphoblastic leukemia
Coustan-Smith, E., Kitanaka, A., Pui, C., McNinch, L., Evans, W., Raimondi, S., Behm, F., Arico, M., & Campana, D. (1996) · Blood · doi:10.1182/blood.v87.3.1140.bloodjournal8731140 · Cited by 208
Shinjyo, T., Kuribara, R., Inukai, T., Hosoi, H., Kinoshita, T., Miyajima, A., Houghton, P. J., Look, A. T., Ozawa, K., & Inaba, T. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.3.854-864.2001 · Cited by 206
O'Brien, S. M., Cunningham, C. C., Golenkov, A. K., Turkina, A. G., Novick, S. C., & Rai, K. R. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.4364 · Cited by 194
Neshat, M. S., Raitano, A. B., Wang, H.-G., Reed, J. C., & Sawyers, C. L. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.4.1179-1186.2000 · Cited by 185
Prokop, A., Wieder, T., Sturm, I., Eβmann, F., Seeger, K., Wuchter, C., Ludwig, W.-D., Henze, G., Dörken, B., & Daniel, P. (2000) · Leukemia · doi:10.1038/sj.leu.2401866 · Cited by 183
The AML1/ETO fusion protein activates transcription of BCL-2
Klampfer, L., Zhang, J., Zelenetz, A. O., Uchida, H., & Nimer, S. D. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.14059 · Cited by 182
Proapoptotic BID is required for myeloid homeostasis and tumor suppression
Zinkel, S. S., Ong, C. C., Ferguson, D. O., Iwasaki, H., Akashi, K., Bronson, R. T., Kutok, J. L., Alt, F. W., & Korsmeyer, S. J. (2003) · Genes & Development · doi:10.1101/gad.1045603 · Cited by 169
Roles of Bim in Apoptosis of Normal and Bcr-Abl-Expressing Hematopoietic Progenitors
Kuribara, R., Honda, H., Matsui, H., Shinjyo, T., Inukai, T., Sugita, K., Nakazawa, S., Hirai, H., Ozawa, K., & Inaba, T. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.14.6172-6183.2004 · Cited by 167
Packham, G., & Stevenson, F. K. (2005) · Immunology · doi:10.1111/j.1365-2567.2005.02117.x · Cited by 162
Expression of BCR/ABL and BCL-2 in myeloid progenitors leads to myeloid leukemias
Jaiswal, S., Traver, D., Miyamoto, T., Akashi, K., Lagasse, E., & Weissman, I. L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1633833100 · Cited by 161
High expression of bcl-2 mRNA as a determinant of poor prognosis in acute myeloid leukemia
Karakas, T., Maurer, U., Weidmann, E., Miething, C. C., Hoelzer, D., & Bergmann, L. (1998) · Annals of Oncology · doi:10.1023/a:1008255511404 · Cited by 160
Kang, M. H., Kang, Y. H., Szymanska, B., Wilczynska-Kalak, U., Sheard, M. A., Harned, T. M., Lock, R. B., & Reynolds, C. P. (2007) · Blood · doi:10.1182/blood-2007-03-080325 · Cited by 159
Andreeff, M., Jiang, S., Zhang, X., Konopleva, M. Y., Estrov, Z. E., Snell, V., Xie, Z., Okcu, M., Sanchez‐Williams, G., Dong, J., et al. (1999) · Leukemia · doi:10.1038/sj.leu.2401573 · Cited by 153
Bcl-2: an antidote to programmed cell death.
Korsmeyer, S. J. (1992) · PubMed · Cited by 152
Feng, H., Stachura, D. L., White, R. M., Gutiérrez, A., Zhang, L., Sanda, T., Jette, C. A., Testa, J. R., Neuberg, D. S., Langenau, D. M., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.09.009 · Cited by 151
de Haar-Holleman, A. (2005) · Blood · doi:10.1182/blood-2005-07-2930 · Cited by 142
Buggins, A. G. S., Milojković, D., Arno, M. J., Lea, N. C., Mufti, G. J., Thomas, N. S. B., & Hirst, W. J. R. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.10.6021 · Cited by 142
Marcucci, G., Stock, W., Dai, G., Klisovic, R. B., Liu, S., Klisovic, M. I., Blum, W. G., Kefauver, C. A., Sher, D. A., Green, M., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.09.118 · Cited by 141
Bcl-2,Bax andp53 expression in B-CLL in relation toin vitro survival and clinical progression
Aguilar‐Santelises, M., Rottenberg, M. E., Lewin, N. L., Mellstedt, H., & Jondal, M. (1996) · International Journal of Cancer · Cited by 137
Antiapoptotic Herpesvirus Bcl-2 Homologs Escape Caspase-Mediated Conversion to Proapoptotic Proteins
Bellows, D. S., Chau, B. N., Lee, P. P., Lazebnik, Y. A., Burns, W. H., & Hardwick, J. M. (2000) · Journal of Virology · doi:10.1128/jvi.74.11.5024-5031.2000 · Cited by 136
Ubiquitin-Independent Degradation of Antiapoptotic MCL-1
Stewart, D. P., Koss, B. S., Bathina, M., Perciavalle, R. M., Bisanz, K. M., & Opferman, J. T. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.01266-09 · Cited by 130
Campana, D., Coustan‐Smith, E., Manabe, A., Buschle, M., Raimondi, S., Behm, F., Ashmun, R. A., Aricò, M., Biondi, A., & Pui, C. (1993) · Blood · doi:10.1182/blood.v81.4.1025.1025 · Cited by 127
Kang, M. H., Wan, Z., Kang, Y. H., Sposto, R., & Reynolds, C. P. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn076 · Cited by 127
Faderl, S. H., Keating, M. J., Do, K.-A., Liang, S.-Y., Kantarjian, H., O'Brien, S. M., García-Manero, G., Manshouri, T., & Albitar, M. X. (2002) · Leukemia · doi:10.1038/sj.leu.2402540 · Cited by 120
Milella, M., Estrov, Z. E., Kornblau, S. M., Carter, B. Z., Konopleva, M. Y., Tari, A. M., Schober, W. D., Harris, D., Leysath, C. E., Lopez‐Berestein, G., et al. (2002) · Blood · doi:10.1182/blood.v99.9.3461 · Cited by 119
Saxena, A., Viswanathan, S., Moshynska, O., Tandon, P., Sankaran, K., & Sheridan, D. P. (2003) · American Journal of Hematology · doi:10.1002/ajh.10453 · Cited by 117
Rochlitz, C. F., Lohri, A., Bacchi, M., Schmidt, M., Nagel, S., Fopp, M., Fey, M., Herrmann, R., & Neubauer, A. (1999) · Leukemia · doi:10.1038/sj.leu.2401484 · Cited by 115
Nückel, H., Frey, U. H., Bau, M., Sellmann, L., Stanelle, J., Dürig, J., Jöckel, K., Dührsen, U., & Siffert, W. (2006) · Blood · doi:10.1182/blood-2006-03-007567 · Cited by 114
Mcl-1: a highly regulated cell death and survival controller
Yang‐Yen, H. (2006) · Journal of Biomedical Science · doi:10.1007/s11373-005-9064-4 · Cited by 108
Mason, K. D., Khaw, S. L., Rayeroux, K. C., Chew, E., Lee, E. F., Fairlie, W. D., Grigg, A., Seymour, J. F., Szer, J., Huang, D. C. S., et al. (2009) · Leukemia · doi:10.1038/leu.2009.151 · Cited by 103
Scorilas, A., Kyriakopoulou, L. G., Yousef, G. M., Ashworth, L. K., Kwamie, A., & Diamandis, E. P. (2001) · Genomics · doi:10.1006/geno.2000.6455 · Cited by 101
Self-citationVogler, M., Dinsdale, D. D., Sun, X.-M., Young, K. W., Butterworth, M., Nicotera, P., Dyer, M. J. S., & Cohen, G. M. (2008) · Cell Death and Differentiation · doi:10.1038/cdd.2008.25 · Cited by 98
Hogarth, L., & Hall, A. G. (1999) · Blood · doi:10.1182/blood.v93.8.2671 · Cited by 91
Kornblau, S. M., Thall, P. F., Estrov, Z. E., Walterscheid, M., Patel, S., Theriault, A., Keating, M. J., Kantarjian, H. M., Estey, E., & Andreeff, M. (1999) · PubMed · Cited by 85
Morales, A. A., Olsson, A., Celsing, F., Österborg, A., Jondal, M., & Osorio, L. M. (2004) · International Journal of Cancer · doi:10.1002/ijc.20614 · Cited by 81
Wuchter, C., Karawajew, L., Ruppert, V., Büchner, T., Schoch, C., Haferlach, T., Ratei, R., Dörken, B., & Ludwig, W.-D. (1999) · Leukemia · doi:10.1038/sj.leu.2401605 · Cited by 80
Zhuang, J., Hawkins, S. F., Glenn, M. A., Lin, K., Johnson, G. G., Carter, A., Cawley, J. C., & Pettitt, A. R. (2009) · Haematologica · doi:10.3324/haematol.2009.010272 · Cited by 77
Apoptosis mechanisms: implications for cancer drug discovery.
Reed, J. C. (2004) · PubMed · Cited by 76
Pharmacological inhibitors of NF-κB accelerate apoptosis in chronic lymphocytic leukaemia cells
Pickering, B. M., Mel, S. D., Lee, M., Howell, M., Habens, F., Dallman, C., Neville, L. A., Potter, K. N., Mann, J., Mann, D. A., et al. (2006) · Oncogene · doi:10.1038/sj.onc.1209897 · Cited by 72
Interferon-γ Has Dual Potentials in Inhibiting or Promoting Cell Proliferation
Asao, H., & Fu, X.-Y. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.2.867 · Cited by 70
Aichberger, K. J., Mayerhofer, M., Gleixner, K. V., Krauth, M., Gruze, A., Pickl, W. F., Wacheck, V., Selzer, E., Müllauer, L., Agis, H., et al. (2006) · Blood · doi:10.1182/blood-2006-07-032714 · Cited by 70
High Bad and Bax mRNA expression correlate with negative outcome in acute myeloid leukemia (AML)
Köhler, T. C., Schill, C., Deininger, M. W., Krahl, R., Borchert, S., Hasenclever, D., Leiblein, S., Wagner, O. F., & Niederwieser, D. W. (2002) · Leukemia · doi:10.1038/sj.leu.2402340 · Cited by 69
Prognostic value of the apoptosis related genes BCL2 and BCL2L12 in breast cancer
Thomadaki, H., Talieri, M., & Scorilas, A. (2006) · Cancer Letters · doi:10.1016/j.canlet.2006.03.016 · Cited by 67
Self-citationQuantitative analysis of bcl-2 expression in normal and leukemic human B-cell differentiation
Menéndez, P. R., Vargas, A., Bueno, C., Barrena, S., Almeida, J., de Santiago, M., López, A., Roa, S., Miguel, J. F. S., & Orfao, A. (2004) · Leukemia · doi:10.1038/sj.leu.2403231 · Cited by 67
Olsson, A., Norberg, M., Ökvist, A., Derkow, K., Choudhury, A., Tobin, G., Celsing, F., Österborg, A., Rosenquist, R., Jondal, M., et al. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603951 · Cited by 66
Laane, E., Tani, E. M., Björklund, E., Elmberger, G., Everaus, H., Skoog, L. K., & Porwit‐MacDonald, A. (2005) · Cytometry Part B Clinical Cytometry · doi:10.1002/cyto.b.20043 · Cited by 65
BAX and PKCalpha modulate the prognostic impact of BCL2 expression in acute myelogenous leukemia.
Kornblau, S. M., Vu, H. T., Ruvolo, P. P., Estrov, Z. E., O'Brien, S. M., Cortes, J. E., Kantarjian, H. M., Andreeff, M., & May, W. S. (2000) · PubMed · Cited by 64
Simonen, M., Keller, H., & Heim, J. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.t01-1-00085.x · Cited by 61
Bcl-XL specifically activates Bak to induce swelling and restructuring of the endoplasmic reticulum
Klee, M., & Pimentel‐Muiños, F. X. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200408169 · Cited by 59
Faderl, S. H., Harris, D., Van, Q., Kantarjian, H. M., Talpaz, M., & Estrov, Z. E. (2003) · Blood · doi:10.1182/blood-2002-06-1890 · Cited by 59
Moshynska, O., Sankaran, K., Pahwa, P., & Saxena, A. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh122 · Cited by 57
Fatal Acute Lymphoblastic Leukemia in Mice Transgenic for B Cell-Restricted bcl-xL and c- myc
Swanson, P. J., Kuslak, S. L., Wei, F., Tze, L. E., Gaffney, P. M., Selby, S. A., Hippen, K. L., Núñez, G., Sidman, C. L., & Behrens, T. W. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.11.6684 · Cited by 55
Vogler, M., Furdas, S. D., Jung, M., Kuwana, T., Dyer, M. J. S., & Cohen, G. M. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0777 · Cited by 54
Turzanski, J., Grundy, M., Russell, N. H., & Pallis, M. (2004) · Leukemia · doi:10.1038/sj.leu.2403457 · Cited by 51
Requirement for Aspartate-cleaved Bid in Apoptosis Signaling by DNA-damaging Anti-cancer Regimens
Werner, A. B., Tait, S. W. G., de Vries, E., Eldering, E., & Borst, J. G. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400268200 · Cited by 51
Abnormalities of the P53, MDM2, BCL2 and BAX genes in acute leukemias.
Wójcik, I., Szybka, M., Golańska, E., Rieske, P., Błoński, J. Z., Robak, T., & Bartkowiak, J. (2005) · PubMed · Cited by 50
FLOROS, K. V., Thomadaki, H., Florou, D., Talieri, M., & Scorilas, A. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1378.009 · Cited by 50
Self-citationMajid, A., Tsoulakis, O., Walewska, R. J., Gesk, S., Siebert, R., Kennedy, D. B., & Dyer, M. J. S. (2007) · Blood · doi:10.1182/blood-2007-07-098681 · Cited by 49
Handa, H., Hegde, U. P., Kotelnikov, V. M., et al. (1997) · Leukemia Research · doi:10.1016/s0145-2126(97)00006-4 · Cited by 49
Bcl-2 antisense therapy in B-cell malignancies
Chanan-Khan, A. A. (2005) · Blood Reviews · doi:10.1016/j.blre.2004.11.002 · Cited by 45
High Bcr-Abl expression prevents the translocation of Bax and Bad to the mitochondrion
Keeshan, K., Cotter, T. G., & McKenna, S. L. (2002) · Leukemia · doi:10.1038/sj.leu.2402576 · Cited by 44
P‐glycoprotein and BCL‐2 levels predict outcome in adult acute lymphoblastic leukaemia
Principe, M. I. D., Poeta, G. D., Maurillo, L., Buccisano, F., Venditti, A., Tamburini, A., Bruno, A., Cox, M. C., Suppo, G., Tendas, A., et al. (2003) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04343.x · Cited by 33
Assessment of Bcl-2 Expression as Modulator of Fas Mediated Apoptosis in Acute Leukemia
Aref, S., Salama, O., Al-Tonbary, Y. A., & Mansour, A. (2004) · Hematology · doi:10.1080/1024533042000205496 · Cited by 29
Antiapoptotic Microenvironment of Acute Myeloid Leukemia
Milojković, D., Devereux, S., Westwood, N., Mufti, G. J., Thomas, N. S. B., & Buggins, A. G. S. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.11.6745 · Cited by 25
Ploner, C., Rainer, J., Lobenwein, S., Geley, S., & Kofler, R. (2009) · APOPTOSIS · doi:10.1007/s10495-009-0355-5 · Cited by 24
Bradbury, D. A., Rogers, S., Kozlowski, R. Z., Bowen, G., Reilly, I. A. G., & Russell, N. H. (1990) · British Journal of Haematology · doi:10.1111/j.1365-2141.1990.tb07905.x · Cited by 24
Floros, K. V., Talieri, M., & Scorilas, A. (2006) · Biological Chemistry · doi:10.1515/bc.2006.203 · Cited by 22
Self-citation
Cited by
Targeting Mitochondrial Structure Sensitizes Acute Myeloid Leukemia to Venetoclax Treatment
Chen, X., Glytsou, C., Zhou, H., Narang, S., Reyna, D. E., Lopez, A., Sakellaropoulos, T., Gong, Y., Kloetgen, A., Yap, Y. S., et al. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-0117 · Cited by 348
miR-150 inhibits terminal erythroid, proliferation and differentiation.
Sun, Z., Wang, Y., Han, X., Zhao, X., Peng, Y., Li, Y., Peng, M., Song, J., Wu, K., Sun, S., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5824 · Cited by 32
Transcription factors and cognate signalling cascades in the regulation of autophagy
Chandra, V., Bhagyaraj, E., Parkesh, R., & Gupta, P. (2016) · Biological Reviews · doi:10.1111/brv.12177 · Cited by 26
Metadata
- Authors
- Tzifi, F., Economopoulou, C., Gourgiotis, D., Ardavanis, A., Papageorgiou, S., & Scorilas, A.
- Venue
- Advances in Hematology
- Publisher
- Hindawi Limited
- Published
- 2012
- Volume
- 2012
- Pages
- 1-15
- ISSN
- 1687-9104 (ISSN-L)
- 1687-9112
- OpenAlex
- W2071450046
- Cited by
- 254
- References
- 108
- FWCI
- 3.76
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.